Theranostics · 2020 · 62 citations · 44 references
Life SciencesImmunologyMicrobiologyDiabetologyMicrobiome ResearchStem Cell BiologyGut MicrobiomeGut MicrobiotaMicrobiome BiomarkersMicrobiome DysbiosisMicrobiome FunctionMicrobiome TherapeuticsAdipose Stem CellsAdipose-derived Mesenchymal Stem CellsAdipose-derived Mesenchymal Stromal CellsGut Microbiome AlterationsGut Microbiome DysbiosisGut Microbiota CompositionGut Microbiota DysbiosisTransplantation
These results provide the rationale for a new approach to improve MSC therapy for T1DM by altering the gut microbiota.
44
NF-κB signaling in inflammation
Ting Liu, Lingyun Zhang, Donghyun Joo et al. · Signal Transduction and Targeted Therapy · 2017 · 8.1K citations · Full text
Life Sciences, Immunology, Pathology +17
Type 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes Association
Jane L. Chiang, M. Sue Kirkman, Lori M. Laffel et al. · Diabetes Care · 2014 · 969 citations · Full text
Medicine, Endocrinology, Immunology +15